IBOV 166,302.02 ▼ 0.74% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL5.95▲ 1.17% USD/MXN19.08▲ 1.16% USD/CLP1,015▲ 0.66% USD/COP3,417▲ 3.32% USD/PEN3.45▲ 0.38% USD/ARS1,565▲ 0.34% USD/UYU40.61▲ 3.19% USD/PYG6,212▲ 2.85% USD/BOB11.64▲ 3.02% USD/DOP59.94▼ 0.43% USD/CRC441.73▲ 2.49% USD/GTQ7.64▲ 3.23% USD/HNL26.89▼ 0.14% USD/NIO36.62▲ 0.26% USD/VES913.46▼ 0.35% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.52▲ 2.37% USD/TTD6.70▲ 2.24% EUR/BRL6.53▲ 2.88% BRENT 89.67 ▼ 2.48% WTI 82.88 ▼ 0.46% IRON ORE 161.91 — — COPPER 5.63 ▼ 0.61% GOLD 3,669 ▼ 1.95% SILVER 44.04 ▼ 2.14% SOY 1,207 ▼ 0.78% CORN 452.75 ▲ 3.96% WHEAT 595.25 ▲ 4.43% COFFEE 275.50 ▼ 1.94% SUGAR 17.15 ▼ 4.93% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.96 ▲ 6.66% COCOA 5,169 ▲ 6.64% BEEF 227.33 ▲ 3.44% CATTLE 335.85 ▼ 0.34% LITHIUM 54.26 ▼ 2.36% PETR4 42.74 ▼ 1.00% VALE3 58.70 ▼ 0.51% ITUB4 39.94 ▼ 0.62% BBDC4 13.82 ▼ 1.85% ABEV3 15.98 ▼ 0.56% BBAS3 14.11 ▼ 0.07% B3SA3 14.23 ▼ 0.49% WEGE3 50.66 ▼ 1.40% PRIO3 59.98 ▼ 3.05% SUZB3 54.98 ▼ 1.12% RENT3 28.97 ▼ 1.63% AZZA3 14.79 ▼ 6.27% CSAN3 3.06 ▼ 2.24% RAIZ4 16.80 ▼ 9.14% PCAR3 3.15 ▲ 5.35% GMAT3 4.10 ▲ 1.23% PSSA3 43.85 ▼ 1.81% CVCB3 0.74 ▼ 5.13% POSI3 3.30 ▲ 4.10% SLCE3 17.45 ▼ 2.40% NATU3 4.53 ▼ 5.23% BRKM5 2.64 ▲ 0.38% RANI3 7.93 ▼ 1.73% IBOV 166,302.02 ▼ 0.74% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL 5.94 ▲ 0.92% USD/MXN 19.09 ▲ 1.25% USD/CLP 1,015 ▲ 0.68% USD/COP 3,416 ▲ 3.30% USD/PEN 3.45 ▲ 0.38% USD/ARS 1,565 ▲ 0.34% USD/UYU 40.61 ▲ 3.19% USD/PYG 6,212 ▲ 2.85% USD/BOB 11.64 ▲ 3.02% USD/DOP 59.94 ▼ 0.43% USD/CRC 441.73 ▲ 2.49% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.89 ▼ 0.14% USD/NIO 36.62 ▲ 0.26% USD/VES 913.46 ▼ 0.35% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.52 ▲ 2.37% USD/TTD 6.70 ▲ 2.24% EUR/BRL 6.52 ▲ 2.69% BRENT 89.67 ▼ 2.48% WTI 82.88 ▼ 0.46% IRON ORE 161.91 — — COPPER 5.63 ▼ 0.61% GOLD 3,669 ▼ 1.95% SILVER 44.04 ▼ 2.14% SOY 1,207 ▼ 0.78% CORN 452.75 ▲ 3.96% WHEAT 595.25 ▲ 4.43% COFFEE 275.50 ▼ 1.94% SUGAR 17.15 ▼ 4.93% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.96 ▲ 6.66% COCOA 5,169 ▲ 6.64% BEEF 227.33 ▲ 3.44% CATTLE 335.85 ▼ 0.34% LITHIUM 54.26 ▼ 2.36% PETR4 42.74 ▼ 1.00% VALE3 58.70 ▼ 0.51% ITUB4 39.94 ▼ 0.62% BBDC4 13.82 ▼ 1.85% ABEV3 15.98 ▼ 0.56% BBAS3 14.11 ▼ 0.07% B3SA3 14.23 ▼ 0.49% WEGE3 50.66 ▼ 1.40% PRIO3 59.98 ▼ 3.05% SUZB3 54.98 ▼ 1.12% RENT3 28.97 ▼ 1.63% AZZA3 14.79 ▼ 6.27% CSAN3 3.06 ▼ 2.24% RAIZ4 16.80 ▼ 9.14% PCAR3 3.15 ▲ 5.35% GMAT3 4.10 ▲ 1.23% PSSA3 43.85 ▼ 1.81% CVCB3 0.74 ▼ 5.13% POSI3 3.30 ▲ 4.10% SLCE3 17.45 ▼ 2.40% NATU3 4.53 ▼ 5.23% BRKM5 2.64 ▲ 0.38% RANI3 7.93 ▼ 1.73%
since 2009
Thursday, November 19, 2026

Brazil Business - Brazil

Brazil Blocks Health Insurer Hapvida From Repricing 947,000 Plans

The company says nobody has formally served it with the order, and it has asked the regulator for a hearing.

By · · 6 min read
Hapvida - illustrative photo of a hospital building in Fortaleza, Brazil
Illustrative photo: Hospital Central de Fortaleza, in the Ceará city where Hapvida is headquartered. The insurer flagged about 947,000 members, some 11% of its 8.67 million health plan users, for repricing or cancellation. (Photo: Joelkaula, CC BY-SA 4.0, Wikimedia Commons.)

Brazil · Business

Key Facts

  • —What happened Brazil’s health regulator ordered Hapvida to stop repricing or cancelling 947,000 health plans.
  • —How big a jump The freeze covers about 11% of Hapvida’s health plan base, and shares fell 5%.
  • —The real story The regulator suspects risk selection, shedding costly patients, which Brazilian rules forbid.
  • —The catch The 947,000 figure may count lives or contracts, and Hapvida says it was not formally notified.
  • —Who it touches Holders of collective plans face free repricing and cancellation, unlike individual plans capped at 5.11%.
  • —What comes next Hapvida must hand over documents and meet agency officials, but no deadline is set.

The company says nobody has formally served it with the order, and it has asked the regulator for a hearing.

Free daily brief — no card needed
Get every Brazil story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Brazil’s health regulator has ordered Hapvida to stop repricing or cancelling almost a million health plans. The agency’s president signed a precautionary order, reported on Thursday, August 20, and summoned the company to explain itself.

Shares in the insurer fell about 5% on the day.

What Brazil’s Regulator Actually Did

Brazil’s private health watchdog is called ANS, short for Agência Nacional de Saúde Suplementar. Its president, Wadih Damous, signed what Brazilian law calls a medida cautelar, a precautionary order.

Because of it, the insurer cannot apply double-digit price rises or terminate the contracts under review. It holds until the company answers the agency’s questions.

This is not a fine, and it is not a final ruling. Instead, it is a freeze button pressed while the regulator investigates the case.

Why Hapvida Flagged 947,000 Members

The number came from Hapvida itself. In fact, its second-quarter report, published on August 12, said roughly 947,000 lives met new commercial review criteria.

That is about 11% of its health plan base. Moreover, the company said those members were either behind on payments or priced below what their care costs.

Because the plan was disclosed to investors, it reached newspapers within a day. After that, the regulator started asking questions.

Live Company IntelligenceHapvida Participações e Investimentos S.A. — the full investor dossierCompany overview and the latest Rio Times coverage.

Contracts or People? The Count Is Murky

Coverage has used two different units for the same 947,000 figure. For example, Valor Econômico described them as lives, while O Globo described them as contracts.

O Globo added that the contracts are mostly collective plans, equal to about 12% of that part of the book. Meanwhile, Damous said the agency still wants the company to state how many consumers sit behind those contracts.

In short, the headline number is firm, yet what it counts is not. That gap is one reason the regulator asked for documents.

The Risk Selection Question

Damous framed the issue bluntly. In fact, he said the move had “a very strong appearance of risk selection, which is prohibited and which ANS will investigate.

Risk selection means shedding the customers who cost the most and keeping the cheap ones. Brazilian rules forbid it, because insurance only works when healthy and sick members share a pool.

So far the agency has not proved that happened here. Still, the size of the group was enough to trigger a formal look.

Hapvida’s Side of the Story

The company pushed back the same day. In a note to Valor, Hapvida said it had not been notified, so it had requested a hearing with the regulator.

It said it was never “called to provide clarification or present the technical, contractual and regulatory elements related to the matter. ” However, that is a procedural complaint, not a denial that a review exists.

On substance, the insurer said the measures involve unpaid bills and the renegotiation of large corporate group contracts that lose money. Moreover, it said it acts in full respect of the law and the regulator.

How Brazil Prices Health Plans

Brazil splits private cover into two very different worlds. For instance, individual and family plans get an annual increase ceiling set by ANS.

For anniversaries between May 2026 and April 2027, that ceiling is 5.11%. By contrast, the previous year’s cap was 6.06%.

Collective plans work differently. Since the agency sets no ceiling for them, the insurer and the contracting company negotiate the number directly.

When an Insurer Can Cancel a Contract

Cancellation rules split along the same line. For example, an individual plan ends only for proven fraud or for non-payment beyond sixty days.

By contrast, collective contracts are far easier to end. The operator may terminate them unilaterally, once the company or association is warned.

Even then, patients already in hospital must be covered until discharge. So the freedom is real, although it is not unlimited.

What the Share Price Says

The market was already jumpy. For instance, on August 13 the stock crashed 33.09% to R$6.41 (about US$1.24), its worst session since November 2025.

By August 19 it had edged back to R$6.56, roughly US$1.27. Then the regulator’s order landed, and the shares gave up about 5% again.

Over twelve months the company has shed some R$14.2 billion in market value, close to US$2.7 billion. In short, that is a fall of about 82%.

The Numbers Behind the Squeeze

The second quarter explains the pressure. For example, adjusted net profit came in at R$12.5 million, near US$2.4 million, down 95.8% in a year.

On a reported basis the company booked a loss of R$217.1 million, about US$41.9 million. Its cash loss ratio, the share of premiums eaten by medical costs, rose to 75.2%.

In addition, legal deposits tied to patient lawsuits reached R$1.2 billion, roughly US$232 million. Membership slipped by 16,000 in the quarter to 8.67 million.

Why the Regulator Is Leaning In

This is not a one-off mood. Damous has argued since taking office in September 2025 that unilateral cancellations often look like risk selection.

Moreover, he has floated stricter rules for group plan increases and tighter protection for older members. Those ideas sit in the agency’s 2026 to 2029 regulatory agenda.

Brazil’s private system covered 53.1 million people in medical plans in June 2026. Therefore any rule change here moves a very large market.

That is why the sector watches the agency closely.

What Happens Next

The company must hand over documents and meet agency officials. Still, no public deadline or meeting date has been announced.

The freeze stays in place while that happens. If the regulator is satisfied, the plan can resume; if not, sanctions become possible.

Neither side has published the full text of the order. Therefore the precise legal scope still rests on press accounts and the two parties’ statements.

What It Means for Foreigners in Brazil

Most foreign residents buy either an individual plan or a company plan. However, only individual plans carry the ANS ceiling and strong cancellation protection.

Company and association plans are cheaper up front, yet they can be repriced freely and ended with notice. That trade-off is exactly what this dispute exposes.

Before signing a Brazilian plan, ask which category it falls into. Overall, the answer decides how much price certainty you actually own.

Frequently Asked Questions

Did ANS cancel anyone’s health plan?

No. The order does the opposite: it stops Hapvida from cancelling or repricing the contracts under review while the agency investigates.

Is the order permanent?

No. It is a precautionary measure, meant to hold the situation still until the company provides explanations and documents.

Does Hapvida accept the order?

The company says it had not been formally notified and has asked for a hearing. It also says the plan targets unpaid bills and loss-making corporate contracts.

Why can collective plans be repriced so sharply?

Because ANS sets no ceiling for them. Only individual and family plans get an annual cap, which is 5.11% for May 2026 to April 2027.

Connected Coverage

Sources: Valor Econômico; O Globo; Folha de S.Paulo; InfoMoney; ANS.

RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.